These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 30952746)

  • 21. The Diagnostic and Prognostic Value of Tumor Markers (CEA, SCC, CYFRA 21-1, TPS) in Head and Neck Cancer Patients.
    Barak V; Meirovitz A; Leibovici V; Rachmut J; Peretz T; Eliashar R; Gross M
    Anticancer Res; 2015 Oct; 35(10):5519-24. PubMed ID: 26408719
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CYFRA 21-1 as a tumor marker for squamous cell carcinoma of the esophagus.
    Nakamura T; Ide H; Eguchi R; Hayashi K; Takasaki K; Watanabe S
    Dis Esophagus; 2017 Nov; 11(1):35-39. PubMed ID: 29040480
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inflammation-based prognostic system predicts postoperative survival of esophageal carcinoma patients with normal preoperative serum carcinoembryonic antigen and squamous cell carcinoma antigen levels.
    Ma Q; Liu W; Jia R; Jiang F; Duan H; Lin P; Zhang L; Long H; Zhao H; Ma G
    World J Surg Oncol; 2016 May; 14():141. PubMed ID: 27151090
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pre-treatment levels of C-reactive protein and squamous cell carcinoma antigen for predicting the aggressiveness of pharyngolaryngeal carcinoma.
    Chen HH; Wang HM; Fan KH; Lin CY; Yen TC; Liao CT; Chen IH; Kang CJ; Huang SF
    PLoS One; 2013; 8(1):e55327. PubMed ID: 23383155
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor marker index based on preoperative SCC and CYFRA 21-1 is a significant prognostic factor for patients with resectable esophageal squamous cell carcinoma.
    Qiao Y; Chen C; Yue J; Yu Z
    Cancer Biomark; 2019; 25(3):243-250. PubMed ID: 31282406
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical significance of osteopontin in esophageal squamous cell carcinoma: comparison with common tumor markers.
    Shimada Y; Watanabe G; Kawamura J; Soma T; Okabe M; Ito T; Inoue H; Kondo M; Mori Y; Tanaka E; Imamura M
    Oncology; 2005; 68(2-3):285-92. PubMed ID: 16015046
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A comparison of serum Cyfra 21-1 and SCC AG in the diagnosis of squamous cell esophageal carcinoma].
    Ychou M; Khemissa-Akouz F; Kramar A; Senesse P; Grenier J
    Bull Cancer; 2001 Oct; 88(10):1023-7. PubMed ID: 11713038
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation between Serum SCCA and CYFRA 2 1-1, Tissue Ki-67, and Clinicopathological Factors in Patients with Esophageal Squamous Cell Carcinoma.
    Sunpaweravong S; Puttawibul P; Sunpaweravong P; Nitiruangjaras A; Boonyaphiphat P; Kemapanmanus M
    J Med Assoc Thai; 2016 Mar; 99(3):331-7. PubMed ID: 27276745
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The assessment of the prognostic value of tumor markers and cytokines as SCCAg, CYFRA 21.1, IL-6, VEGF and sTNF receptors in patients with squamous cell cervical cancer, particularly with early stage of the disease.
    Kotowicz B; Fuksiewicz M; Jonska-Gmyrek J; Bidzinski M; Kowalska M
    Tumour Biol; 2016 Jan; 37(1):1271-8. PubMed ID: 26289850
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Can initial serum cyfra 21-1, SCC antigen, and TPA levels in squamous cell cervical cancer predict lymph node metastases or prognosis?
    Gaarenstroom KN; Kenter GG; Bonfrer JM; Korse CM; Van de Vijver MJ; Fleuren GJ; Trimbos JB
    Gynecol Oncol; 2000 Apr; 77(1):164-70. PubMed ID: 10739706
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preoperative Cyfra21-1 and SCC-Ag serum titers predict survival in patients with stage II esophageal squamous cell carcinoma.
    Cao X; Zhang L; Feng GR; Yang J; Wang RY; Li J; Zheng XM; Han YJ
    J Transl Med; 2012 Sep; 10():197. PubMed ID: 22999061
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of CYFRA 21-1 and squamous cell carcinoma antigen in detecting nasopharyngeal carcinoma.
    Lee JK; Hsieh JF; Tsai SC; Ho YJ; Sun SS; Kao CH
    Ann Otol Rhinol Laryngol; 2001 Aug; 110(8):775-8. PubMed ID: 11510737
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Salivary and serum level of CYFRA 21-1 in oral precancer and oral squamous cell carcinoma.
    Rajkumar K; Ramya R; Nandhini G; Rajashree P; Ramesh Kumar A; Nirmala Anandan S
    Oral Dis; 2015 Jan; 21(1):90-6. PubMed ID: 24304502
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monitoring carcinogenesis in a case of oral squamous cell carcinoma using a panel of new metabolic blood biomarkers as liquid biopsies.
    Grimm M; Hoefert S; Krimmel M; Biegner T; Feyen O; Teriete P; Reinert S
    Oral Maxillofac Surg; 2016 Sep; 20(3):295-302. PubMed ID: 26875085
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of Cyfra 21-1 and SCC assays in head and neck tumours.
    Banal A; Hacene K; Berthelot-Ruff E; Mahé E; Fontana X; Pichon MF
    Tumour Biol; 2001; 22(1):27-35. PubMed ID: 11054024
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum level of cytokeratin 19 fragment (CYFRA 21-1) indicates tumour stage and prognosis of squamous cell carcinoma of the oesophagus.
    Tsuchiya Y; Onda M; Miyashita M; Sasajima K
    Med Oncol; 1999 Apr; 16(1):31-7. PubMed ID: 10382940
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Utility of squamous cell carcinoma antigen, carcinoembryonic antigen, Cyfra 21-1 and neuron specific enolase in lung cancer diagnosis: a prospective study from China.
    Song WA; Liu X; Tian XD; Wang W; Liang CY; Zhang T; Guo JT; Peng YH; Zhou NK
    Chin Med J (Engl); 2011 Oct; 124(20):3244-8. PubMed ID: 22088515
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Roles of preoperative C-reactive protein are more relevant in buccal cancer than other subsites.
    Tai SF; Chien HT; Young CK; Tsao CK; de Pablo A; Fan KH; Liao CT; Wang HM; Kang CJ; Chang JT; Huang SF
    World J Surg Oncol; 2017 Feb; 15(1):47. PubMed ID: 28209200
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of pre-treatment CYFRA 21 - 1 and SCC-Antigen assay in primary cervical carcinoma - a preliminary report.
    Puthucode-Easwaran S; Naik R; Athavale R; Handley G; Lopes A; Godfrey K; Hatem M
    J Obstet Gynaecol; 2005 Jul; 25(5):486-8. PubMed ID: 16183586
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum squamous cell carcinoma antigen and CYFRA 21-1 in cervical cancer treatment.
    Pras E; Willemse PH; Canrinus AA; de Bruijn HW; Sluiter WJ; ten Hoor KA; Aalders JG; Szabo BG; de Vries EG
    Int J Radiat Oncol Biol Phys; 2002 Jan; 52(1):23-32. PubMed ID: 11777619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.